HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Herbert O. Vetter Christoph Schmitz Bruno Reichart Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vetter, H. O. Articles by Frater, S. b. R. W. M. Search for Related Content PubMed PubMed Citation Articles by Vetter, H. O. Articles by Frater, S. b. R. W. M.

J Thorac Cardiovasc Surg 1995;109:74-80
© 1995 Mosby, Inc.

CARDIOPULMONARY BYPASS, MYOCARDIAL MANAGEMENT, AND SUPPORT TECHNIQUES

Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system

Munich, Germany, Bronx, N.Y.

Address for reprints: Herbert O. Vetter, MD, Department of Cardiac Surgery, Grosshadern Medical Center, University of Munich, 81366 Munich, Germany.

Abstract

The three components of the Novacor left ventricular assist system, compact controller, battery, and back-up battery, have been miniaturized in the development of the wearable system. Therefore patients can be fully mobilized receiving mechanical circulatory support while awaiting heart transplantation. Between February 1992 and April 1994 a total of eight patients with decompensated heart failure (6 dilated cardiomyopathy, 1 acute myocarditis, 1 ischemic cardiomyopathy) were treated with the Novacor left ventricular assist system. In the most recent four cases the wearable system (N100P) was used. Patients' ages ranged from 17 to 49 years. In five patients severe failure of the right side of the heart was present at the time of implantation. Hemodynamic stabilization was achieved in all patients during the 2 to 122 days (mean 30.8 ± 42.5 days) of support. The following parameters were measured on average before and 24 hours after implantation of the left ventricular assist system: mean arterial pressure 70 ± 11 versus 87 ± 13 mm Hg (p < 0.05), cardiac index 1.71 ± 0.42 versus 3.23 ± 0.74 L/min/m² (p < 0.05), pulmonary capillary wedge pressure 27.1 ± 4.4 versus 9.9 ± 5.2 mm Hg (p < 0.01), mean pulmonary pressure 41 ± 9 versus 27 ± 6 mm Hg (p < 0.05), and right ventricular ejection fraction 16.7% ± 10.3% versus 22.0% ± 11.6% (not significant). Patients who received the wearable system were capable of managing their own power supply during the bridging period and were able to walk to the hospital park and shopping area. One patient had a serious pulmonary infection, which was treated successfully, and two patients had a cerebrovascular accident, which resolved in one and resulted in a minor residual deficit in the other. All eight patients received a heart transplant. One patient died early after transplantation and seven patients are alive and well. In summary, the wearable Novacor left ventricular assist system provides major advantages regarding quality of life of patients during mechanical circulatory support. However, there is a remaining risk of thromboembolism despite anticoagulation therapy. (J THORAC CARDIOVASC SURG 1995;109:74-80)

This article has been cited by other articles:

				M. Rinaldi, F. Pagani, F. Gazzoli, A. Alloni, D. Ricci, and M. Vigano Left ventricular assistance from bridge to transplantation to destination therapy. The Pavia experience Eur. Heart J. Suppl., November 1, 2004; 6(suppl_F): F81 - F86. [Abstract] [Full Text] [PDF]

				D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF]

				M. Rothenburger, M. J. Wilhelm, D. Hammel, C. Schmidt, T. D. T. Tjan, D. Bocker, H. H. Scheld, and C. Schmid Treatment of Thrombus Formation Associated With the MicroMed DeBakey VAD Using Recombinant Tissue Plasminogen Activator Circulation, September 24, 2002; 106(12_suppl_1): I-189 - I-192. [Abstract] [Full Text] [PDF]

				R. A. Vilchez, M. C. McEllistrem, L. H. Harrison, K. R. McCurry, R. L. Kormos, and S. Kusne Relapsing bacteremia in patients with ventricular assist device: an emergent complication of extended circulatory support Ann. Thorac. Surg., July 1, 2001; 72(1): 96 - 101. [Abstract] [Full Text] [PDF]

				A. Koster, M. Loebe, R. Hansen, E. V. Potapov, G. P. Noon, H. Kuppe, and R. Hetzer Alterations in coagulation after implantation of a pulsatile Novacor LVAD and the axial flow micromed DeBakey LVAD Ann. Thorac. Surg., August 1, 2000; 70(2): 533 - 537. [Abstract] [Full Text] [PDF]

				I. Di Bella, F. Pagani, C. Banfi, E. Ardemagni, A. Capo, C. Klersy, and M. Vigano Results with the Novacor assist system and evaluation of long-term assistance Eur. J. Cardiothorac. Surg., July 1, 2000; 18(1): 112 - 116. [Abstract] [Full Text] [PDF]

				C. Schmitz, A. Welz, O. Dewald, R. Kozlik-Feldmann, H. Netz, and B. Reichart Switch from a BIVAD to a LVAD in a boy with Kawasaki disease Ann. Thorac. Surg., April 1, 2000; 69(4): 1270 - 1271. [Abstract] [Full Text] [PDF]

				A. El-Banayosy, M. Deng, D.Y. Loisance, H. Vetter, E. Gronda, M. Loebe, and M. Vigano The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study Eur. J. Cardiothorac. Surg., June 1, 1999; 15(6): 835 - 841. [Abstract] [Full Text] [PDF]

				V. Kasirajan, N. G. Smedira, J. Perl II, and P. M. McCarthy Cerebral embolism associated with left ventricular assist device support and successful therapy with intraarterial urokinase Ann. Thorac. Surg., April 1, 1999; 67(4): 1148 - 1150. [Abstract] [Full Text] [PDF]

				C. Schmid, M. Weyand, D. G. Nabavi, D. Hammel, M. C. Deng, E. B. Ringelstein, and H. H. Scheld Cerebral and Systemic Embolization During Left Ventricular Support With the Novacor N100 Device Ann. Thorac. Surg., June 1, 1998; 65(6): 1703 - 1710. [Abstract] [Full Text] [PDF]

				M. Vigano, S. Scuri, F. Cobelli, C. Opasich, F. M. Pagani, G. Minzioni, L. Martinelli, L. Tavazi, and M. Vigano Staged discharge out of hospital of the Novacor left ventricular assist system (LVAS) recipients Eur. J. Cardiothorac. Surg., April 1, 1997; 11(suppl): S45 - S50. [Abstract] [PDF]

				D.G. Nabavi, D. Georgiadis, T. Mumme, C. Schmid, T.G. Mackay, H.H. Scheld, and E.B. Ringelstein Clinical Relevance of Intracranial Microembolic Signals in Patients With Left Ventricular Assist Devices : A Prospective Study Stroke, May 1, 1996; 27(5): 891 - 896. [Abstract] [Full Text]

				Short-Term Experience with Portable LVADs for Transplant Candidates Journal Watch Cardiology, March 1, 1995; 1995(301): 8 - 8. [Full Text]